Axxam at Drug Discovery Chemistry 2025 – Driving Innovation in Small Molecule Research

Axxam is pleased to participate in this engaging conference, a leading conference dedicated to the latest advancements in small molecule drug discovery, medicinal chemistry, and emerging therapeutic strategies. This event brings together top scientists, industry leaders, and innovators to explore breakthroughs in protein-protein interactions (PPIs), RNA-targeted therapeutics, covalent inhibitors, and AI-driven drug design.

Maria Pia, our Lead Discovery Services Director will attend, engaging in key discussions on rational drug design, hit-to-lead strategies, and the evolving landscape of molecular therapeutics. With a strong background in high-throughput screening (HTS), targeted compound profiling, and mechanistic studies, Axxam continues to push the boundaries of early drug discovery by integrating innovative technologies with deep biological expertise.

Axxam specializes in identifying and optimizing small molecules for challenging drug targets, leveraging proprietary assay development, screening platforms, and data-driven approaches to accelerate discovery efforts. Our expertise spans a wide range of disease areas, including oncology, neuroscience, metabolic disorders, and rare diseases.

At Drug Discovery Chemistry, we look forward to exchanging insights with fellow researchers, discussing the latest trends in chemical biology and bioactive molecules, and fostering collaborations with academic and industry partners. As the pharmaceutical landscape continues to evolve, staying at the forefront of fragment-based drug discovery, allosteric modulation, and computational chemistry is crucial for advancing next-generation therapeutics.

If you are attending, don’t miss the opportunity to connect with us. We welcome discussions on how our screening technologies, chemosensory receptor expertise, and compound libraries can support your research and drug development goals.

Follow us for updates from the conference and insights into how Axxam is shaping the future of drug discovery!